Screening of FVIII inhibitors in hemophilia a patients using the modified Bethesda assay in the west of Algeria

被引：0
|
作者：
Benlaldj, D. [1 ]
Moulasserdoun, K. [2 ]
Rahal, C. [2 ]
Seghier, F. [2 ]
机构：
[1] Univ Hosp Ctr Oran, Dept Haemobiol, Oran, Algeria
[2] Ctr Hosp Oran, Dept Haemobiol, Oran, Algeria
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-521
引用
收藏
页码：684 / 684
页数：1
相关论文
共 50 条
  • [31] Immunomodulation of Factor FVIII Inhibitors in Hemophilia A Mice Using Messenger RNA Lipid Nanoparticles
    Chen, Chun-Yu
    Rajendran, Raj
    Cai, Xiaohe
    Cavedon, Alex
    Lyle, Meghan J.
    Martini, Paolo
    Miao, Carol H.
    MOLECULAR THERAPY, 2019, 27 (04) : 181 - 182
  • [32] A high performance of Nijmegen-Bethesda assay in therapy to induce immune tolerance for hemophilia patients
    Montalvao, S. L.
    Tucunduva, A.
    Machado, T. G. S.
    Quaino, S. P.
    Colella, M. P.
    De Paula, E., V
    Medina, De Souza S.
    Ozelo, M. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 262 - 263
  • [33] The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A
    Valke, Lars L. F. G.
    Verhagen, Marieke J. A.
    Mulders, Bart T. P. M.
    Polenewen, Robert
    Blijlevens, Nicole M. A.
    Jansen, Joop H.
    Mansouritorghabeh, Hassan
    Elsheikh, Einas
    Reipert, Birgit M.
    Turecek, Peter L.
    O'Donnell, James S.
    Rijpma, Sanna R.
    Schols, Saskia E. M.
    Heerde, Waander L. van
    Meijer, Danielle
    THROMBOSIS RESEARCH, 2023, 231 : 112 - 120
  • [34] Detection of factor VIII inhibitors, a comparison of an inhibitor screening test and Bethesda assay in children with haemophilia A
    Burgess, C. A.
    Alaoye, F. A.
    Liesner, R.
    Mathias, M.
    Khair, K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 30 - 30
  • [35] Presence and evolution of anti-factor VIII (FVIII) catalytic activity in severe, mild, or moderate hemophilia patients with FVIII inhibitors
    Grosbois, S.
    Francois-Brionne, M.
    Vallee, E.
    Gautier, P.
    Repesse, Y.
    Borel-Derlona, A.
    HAEMOPHILIA, 2012, 18 : 89 - 89
  • [36] Agreement between a chromogenic modified Nijmegen-Bethesda Assay and a qualitative ELISA test in detection of Factor VIII inhibitors in plasma from Persons with Hemophilia A (PwHA)
    Boylan, Marc
    Chen, David
    Adamkewicz, Joanne
    Sadeghi-Khomami, Ali
    HAEMOPHILIA, 2018, 24 : 46 - 46
  • [37] RESOURCE CONSUMPTION ANALYSIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS ON PROPHYLAXIS WITH FVIII BEFORE SWITCHING TO EMICIZUMAB
    Giacomini, E.
    Leogrande, M.
    Motta, L.
    Tempre, R.
    Bendinelli, S.
    Degli Esposti, L.
    VALUE IN HEALTH, 2023, 26 (12) : S69 - S69
  • [38] Initial results of a collaborative nursing service aimed at improving adherence in hemophilia A patients with inhibitors to FVIII
    Stephensen, David
    Wakelen, Della
    HAEMOPHILIA, 2016, 22 : 80 - 81
  • [39] IgG subclasses of FVIII inhibitors in an argentine cohort of severe hemophilia A patients: Analysis by flow cytometry
    Irigoyen, M. B.
    Primiani, L.
    Felippo, M.
    Candela, M.
    de Bracco, M. M. E.
    Galassi, N. V.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (06) : 569 - 576
  • [40] THE FREQUENCY AND SIGNIFICANCE OF CROSSREACTING ANTI-PORCINE FVIII INHIBITORS IN PATIENTS WITH CONGENITAL AND ACQUIRED HEMOPHILIA A
    Stephen, Maddie S.
    Elbaz, Carolyne
    Hanif, Hina
    Ombao, Russell
    Gan, Jenny
    Pavenski, Katerina
    Teitel, Jerry
    Sholzberg, Michelle
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E105 - E106
12345